Talis Biomedical Corporation (TLIS) OTC

1.38

-0.12(-8.00%)

Updated at October 02 03:13PM

Currency In USD

Talis Biomedical Corporation

Address

230 Constitution Drive

Menlo Park, CA 94025

United States of America

Phone

650 433 3000

Sector

Healthcare

Industry

Medical - Devices

Employees

99

First IPO Date

February 12, 2021

Key Executives

NameTitlePayYear Born
Ms. Rebecca MarkovichInterim Chief Financial Officer379,2341974
Gillian GreenCompany Secretary0N/A
Ms. Margaret Barrett M.S.Controller0N/A

Description

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.